Marksans Pharma Market Cap

Marksans Pharma has a market cap or net worth of 102.44 billion as of February 21, 2025. Its market cap has increased by 47.50% in one year.

Market Cap

102.44B

Enterprise Value

97.94B

Revenue

24.74B

Ranking

n/a

PE Ratio

27.80

Stock Price

226.05

Market Cap Chart

Since December 13, 2006, Marksans Pharma's market cap has increased from 36.52B to 102.44B, an increase of 180.53%. That is a compound annual growth rate of 5.83%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	102.44B	-23.80%
Dec 31, 2024	134.43B	84.14%
Dec 29, 2023	73.00B	210.96%
Dec 30, 2022	23.48B	-4.66%
Dec 31, 2021	24.63B	-0.80%
Dec 31, 2020	24.82B	263.17%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,005.21B
Divi's Laboratories	1,587.05B
Cipla	1,195.03B
Mankind Pharma	968.92B
Apollo Hospitals Enterprise	918.92B
Zydus Lifesciences	905.26B
Aurobindo Pharma	651.22B
Alkem Laboratories	564.35B

Market Cap Rankings